Background This study examined whether mismatch negativity (MMN) responses are
impaired in participants at clinical high risk for psychosis (CHR-P) and patients with first …

Objective: Remission in schizophrenia patients is associated with neurocognitive, social,
and role functioning during both the early and chronic stages of schizophrenia. It is well …

The “Decade of the Brain” referred to the 1990s, as the emergence of various brain imaging
techniques allowed the analysis of both normal and pathological behaviors with specific …

Recent clinical studies have shown that agonists at muscarinic acetylcholine receptors
effectively reduce schizophrenia symptoms. It is thus conceivable that, for the first time, a …

Background: There have been conflicting reports on whether conventional verbal fluency
measures can predict the prognosis of individuals at clinical high risk (CHR) for psychosis …

Electroencephalography (EEG) is widely accessible and can be relatively easily applied in
clinical settings. This chapter is focused on selected quantitative electroencephalographic …

Rationale Social defeat (SD) and cognition have been positioned as features of those at
high-risk of developing psychosis (McCleery and Nuechterlein, 2019; Selten and Cantor …

Objective: Remission in schizophrenia patients is associated with neurocognitive, social,
and role functioning during both the early and chronic stages of schizophrenia. It is well …

Schizophrenia is a neuropsychiatric illness affecting nearly 1% of the population (McGrath,
Saha, Chant, & Welham, 2008) and it is characterised by three main clusters of symptoms …

In this study, the role of cytokines in predicting treatment outcome of first-episode psychosis
(FEP) patients will be assessed. Background: Schizophrenia is a chronic mental disorder in …